5 completed, 3 active not recruiting, 2 recruiting, 1 unknown. 5 Not applicable, 5 Phase 2, 2 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 5 | Completed 3, Active not recruiting 2 |
| Phase 2 | 5 | Completed 2, Recruiting 2, Active not recruiting 1 |
| Phase 1 | 2 | Recruiting 1, Unknown 1 |
| Phase 3 | 1 | Completed 1 |
Follow Pterocarpus marsupium: new trials by email Literature Review of Pterocarpus marsupium trials Research Report on Pterocarpus marsupium
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Research On Nicotinamide Riboside Supplement Support in MDS (ROSS Trial) Nicotinamide Riboside, Pterostilbene - Clonal Cytopenia of Undetermined Significance, Myelodysplastic Syndrome | Phase 2 | Recruiting | University of Colorado, Denver | 10 | 2026-05-20 | 2026-06-03 |
| Evaluation of the Combined Therapy of EH-301 and N-acetylcysteine Together With Riluzole in Amyotrophic Lateral Sclerosis (ALS) Acetylcysteine, EH301, Riluzole - Amyotrophic Lateral Sclerosis | Phase 1 / Phase 2 | Recruiting | Biogipuzkoa Health Research Institute | 90 | 2025-11-25 | 2026-02-17 |
| A Trial of Nicotinamide/Pterostilbene Supplement in ALS: The NO-ALS Extension Study EH301 (Nicotinamide Riboside/Pterostilbene) - Amyotrophic Lateral Sclerosis | Not applicable | Active not recruiting | Haukeland University Hospital | 300 | 2021-10-07 | 2026-09-21 |
| Effects of a Seven-day BASIS™ Supplementation on Menopausal Syndromes and Measurements of the Urinary Vitamin B3 and Estradiol Levels in Pre-, Peri- and Post-menopause BASIS™ (Crystalline Nicotinamide Riboside 250mg and Pterostilbene 50mg) - Menopause | Not applicable | Completed | University of South Alabama | 40 | 2021-04-05 | 2021-11-18 |
| Protection From Acute Kidney Injury (AKI) With Basis™ Treatment Nicotinamide Riboside + Pterostilbene, Placebo - AKI | Phase 2 | Completed | Mayo Clinic | 54 | 2020-12-01 | 2024-04-23 |
| The NO-ALS Study: A Trial of Nicotinamide/Pterostilbene Supplement in ALS. EH301 (Nicotinamide Riboside/Pterostilbene) - Amyotrophic Lateral Sclerosis | Not applicable | Active not recruiting | Haukeland University Hospital | 380 | 2020-10-07 | 2026-10-05 |
| Effect of Nicotinamide Riboside and Pterostilbene Supplementation on Muscle Regeneration in Elderly Humans Placebo (twice daily), Nicotinamide Riboside/Pterostilbene (500 mg/100 mg twice daily) - Muscle Injury | Not applicable | Completed | University of Aarhus | 32 | 2019-02-12 | 2020-11-05 |
| Megestrol Acetate With or Without Pterostilbene in Treating Patients With Endometrial Cancer Undergoing Hysterectomy Megestrol Acetate, Pterostilbene - Atypical Endometrial Hyperplasia, Endometrial Carcinoma | Phase 2 | Active not recruiting | City of Hope Medical Center | 44 | 2019-01-21 | 2026-06-03 |
| Basis: Evaluating Sirtuin Supplements To Benefit Elderly Trauma Patients (BES2T BET) Nicotinamide Riboside and Pterostilbene, Placebo - Recovery of Function | Phase 1 | Unknown | Elysium Health | 48 | 2018-12-06 | 2020-01-06 |
| Pharmacokinetics, Pharmacodynamics and Safety of Basis in Acute Kidney Injury Study Basis, Placebo - Acute Kidney Injury | Not applicable | Completed | Massachusetts General Hospital | 24 | 2017-11-01 | 2019-06-27 |
| Effect of Pterostilbene on Cholesterol, Blood Pressure and Oxidative Stress Pterostilbene 50 mg twice daily, Placebo, Grape Extract - Hyperlipidemia, Blood Pressure | Phase 2 / Phase 3 | Completed | University of Mississippi Medical Center | 80 | 2010-12-01 | 2018-01-10 |
Amyotrophic Lateral Sclerosis (3) · Acute Kidney Injury (2) · Endometrial Hyperplasia (1) · Endometrial Neoplasms (1) · Hot Flashes (1) · Hyperlipidemias (1) · Myelodysplastic Syndromes (1)
Haukeland University Hospital (2) · Biogipuzkoa Health Research Institute (1) · City of Hope Medical Center (1) · Elysium Health (1) · Massachusetts General Hospital (1) · Mayo Clinic (1) · University of Aarhus (1) · University of Colorado, Denver (1) · University of Mississippi Medical Center (1) · University of South Alabama (1)
United States (7) · Norway (2) · Denmark (1) · Spain (1)
Bernardo Mendes, MD (1) · Carrie Sims (1) · Daniel M Riche, Pharm.D. (1) · Eugene Rhee, MD (1) · Maria Amaya, PhD MD (1) · Thanh H Dellinger (1)
PMID 21525161, PMID 23431291, PMID 25057276, PMID 2554542, PMID 25660429, PMID 26491826, PMID 27552971, PMID 28041599, PMID 28816586, PMID 28915830, PMID 29883761, PMID 32791973, PMID 35998039, PMID 42211736
P30CA033572 (1)